Navigation Links
Wexford Science & Technology Makes $150 Million Investment in Wake Forest Innovation Quarter
Date:5/9/2013

WINSTON-SALEM, N.C., May 9, 2013 /PRNewswire-USNewswire/ -- Wexford Science & Technology, LLC, Wake Forest Baptist Medical Center's development partner in the Wake Forest Innovation Quarter, today announced that the renovation of two former Reynolds Tobacco buildings currently underway represents an additional $150 million investment in downtown Winston-Salem. This brings Wexford's total investment in the Innovation Quarter to more than $250 million, the largest capital investment in the history of downtown Winston-Salem.

(Logo: http://photos.prnewswire.com/prnh/20111114/DC06171LOGO)

"This is the tipping point for Innovation Quarter," said John D. McConnell, M.D., chief executive officer at Wake Forest Baptist Medical Center. "As a result of this unique public-partnership the city, county and region will all benefit significantly."

The two buildings, formerly part of the "90 Series" of buildings, will be named "525 Vine" and "635 Vine" to represent their physical locations, and have a total of 473,000 square feet. The 230,000 square feet in 525 Vine will be developed for multi-tenant use that includes state-of-the-art labs, offices and educational facilities. Inmar's future corporate headquarters will be located at 635 Vine. Wexford expects to complete the 242,000 square foot renovation in the first quarter of 2014.

"This is a further significant milestone in our progress to create a dynamic hub for innovation in medical science and information technology in Winston-Salem, said Eric Tomlinson, D.Sc., Ph.D., chief innovation officer, Wake Forest Baptist Medical Center, and president, Wake Forest Innovation Quarter. "We are delighted by Wexford's work and look forward to them working with Inmar and others in creating distinctive work spaces that will maintain the inspirational nature of the Innovation Quarter."

The renovation of 525 Vine and 635 Vine builds upon the success of Wake Forest Biotech Place, Wexford's first development in Wake Forest Innovation Quarter. "To have an opportunity to be part of what is taking place at Innovation Quarter is truly an investment in the future of medical research and innovation in biomedical science and information technology," said Dan Cramer , executive vice present, Wexford Science & Technology, LLC.

Wexford is a private real estate investment and development company that owns and develops institutional quality life science real estate for academic and medical research organizations and is based in Baltimore, Maryland. Wexford recently announced a merger with life science giant, BioMed Realty Trust, Inc., a $4 billion real estate investment trust based in San Diego, California.

Note: Photos available.

Wake Forest Baptist Medical Center (www.wakehealth.edu) is a fully integrated academic medical center located in Winston-Salem, North Carolina. The institution comprises the medical education and research components of Wake Forest School of Medicine, the integrated clinical structure and consumer brand Wake Forest Baptist Health, which includes North Carolina Baptist Hospital and Brenner Children's Hospital, the creation and commercialization of research discoveries into products that benefit patients and improve health and wellness, through Wake Forest Innovations (WakeForestInnovations.com),Wake Forest Innovation Quarter (WakeForestInnovationQuarter.com), a leading center of technological discovery, development and commercialization, as well as a network of affiliated community-based hospitals, physician practices, outpatient services and other medical facilities. Wake Forest School of Medicine is ranked among the nation's best medical schools and is a leading national research center in fields such as regenerative medicine, cancer, neuroscience, aging, addiction and public health sciences. Wake Forest Baptist 's clinical programs have consistently ranked as among the best in the country by U.S .News & World Report for the past 20 years.


'/>"/>
SOURCE Wake Forest Baptist Medical Center
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. R. Graham Cooks wins Dreyfus Prize in the Chemical Sciences
2. New ACS journal Environmental Science and Technology Letters to rapidly publish urgent research
3. GSAs top geoscience journal posts 9 new articles
4. Freeman elected to National Academy of Science
5. PLOS announces Accelerating Science Award Program
6. The science of spring flowers -- how petals get their shape
7. 3 NYU faculty elected to National Academy of Sciences
8. Carnegies Greg Asner elected to National Academy of Sciences
9. Geosphere features top geoscience technology, including LiDAR, EarthScope, CHIRP, ALSM, and IODP
10. Science surprise: Toxic protein made in unusual way may explain brain disorder
11. Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
Breaking Biology News(10 mins):
(Date:3/1/2017)... WA (PRWEB) , ... March 01, 2017 , ... ... research into the physiology of aging into clinical applications, announces the formation of ... proprietary oral-transmucosal dosage form of resveratrol, the drug which has been discussed in ...
(Date:2/28/2017)... Linda, Ca (PRWEB) , ... February 28, 2017 , ... ... molecular interactions. SPR is an optical phenomenon that is sensitive to changes in the ... resonance condition is affected by changes in refractive index occurring up to 300 nm ...
(Date:2/28/2017)... , Feb. 28, 2017  Phosphorus, a ... today the formation of the Phosphorus Scientific Advisory ... experts chosen to advise the company on the ... multi-site research initiatives. Please visit http://phosphorus.com/about-us/ ... initiatives. "We,ve gathered some of the ...
(Date:2/28/2017)... -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing ... diseases, asthma and allergic diseases and cancer, today ... full year ended December 31, 2016 and provided ... clinical highlights. "During 2016, we made ... starting five clinical trials across our XmAb portfolio.  ...
Breaking Biology Technology: